Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/India/Amycretin / Zenagamtide
Purchase and availability checkAmycretin / Zenagamtide in India

Can you buy Amycretin in India?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Amycretin / Zenagamtide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
India
Source records
3
Reviewed
24 July 2026
ByPeptide Local Editorial DeskUpdated 24 July 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Amycretin in India?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Amycretin / Zenagamtide is an investigational clinical program. No seller listing in India can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Amycretin / Zenagamtide in India?

Resolve the exact identity of Amycretin / Zenagamtide through AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414 from ClinicalTrials.gov. Then search Approved new drugs from Central Drugs Standard Control Organization for the destination product record and Drug and quality alerts from Central Drugs Standard Control Organization for the seller, establishment, or supply route in India. A match in one record does not replace the other two checks.

03

Does an online listing prove Amycretin / Zenagamtide is authorized or available in India?

No. A page using the name Amycretin / Zenagamtide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For India, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Amycretin / Zenagamtide clinical trials in India

5 study records currently list 110 locations in this country, including 0 locations individually marked Recruiting.

Registry update: 24 July 2026
Study records
5
Listed locations
110
Recruiting locations
0
Records with local recruiting sites
0
NCT07567001
Study-wide statusRecruiting

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Listed locations
45
Recruiting locations
0
Registry update
2026-07-15
NCT07571005
Study-wide statusRecruiting

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Listed locations
13
Recruiting locations
0
Registry update
2026-07-13
NCT07571109
Study-wide statusRecruiting

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Listed locations
13
Recruiting locations
0
Registry update
2026-07-13
NCT07668401
Study-wide statusNot yet recruiting

AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight

Listed locations
21
Recruiting locations
0
Registry update
2026-07-21
NCT07400107
Study-wide statusNot yet recruiting

AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Listed locations
18
Recruiting locations
0
Registry update
2026-03-12
Continue the exact comparison

Related country and compound records.

Compare another tracked name in India, or keep Amycretin / Zenagamtide fixed and change the destination within Asia-Pacific. The identity, product, and seller checks remain separate.

Continue the exact comparison

Amycretin / Zenagamtide in Asia-Pacific

Amycretin / Zenagamtide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Amycretin / Zenagamtide is an investigational clinical program. No seller listing in India can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414

AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414 ↗

Approved new drugs

Approved new drugs is maintained by Central Drugs Standard Control Organization. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Approved new drugs ↗

Drug and quality alerts

Drug and quality alerts is maintained by Central Drugs Standard Control Organization. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drug and quality alerts ↗
India / Country guide

India market context.

India's medicine oversight combines central responsibilities with state licensing and enforcement. CDSCO publishes new-drug approvals and quality or spurious-product alerts, but neither list by itself verifies a clinic, pharmacy, imported research listing, or local seller claim.

  • CDSCO's approved new-drug page publishes dated national approval lists, including a 2026 list, and should be checked for the exact product context.
  • The CDSCO alert index separately publishes quality, spurious-product, recall, and related notices that can change the evidence for a named batch or offer.
  • A peptide seller page, laboratory report, or foreign shipping claim is not a substitute for the relevant central product and state establishment records in India.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the central approval list

Search CDSCO's approved new-drug records for the exact name and approval period. Do not treat a foreign authorization, sponsor announcement, or ingredient match as an Indian approval entry.

02

Review current quality alerts

Check CDSCO alerts for not-of-standard-quality and spurious batches. An approval record and a later batch alert answer different questions and both may matter.

03

Identify the state record

Pharmacy and sale permissions may depend on the relevant State Drug Control authority, so match the business and jurisdiction instead of assuming a central product entry verifies the seller.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414ClinicalTrials.gov
02
Approved new drugsCentral Drugs Standard Control Organization
03
Drug and quality alertsCentral Drugs Standard Control Organization
04
Zenagamtide study search in IndiaClinicalTrials.gov
05
NCT07567001: A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityClinicalTrials.gov
06
NCT07571005: AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaClinicalTrials.gov
07
NCT07571109: AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaClinicalTrials.gov
08
NCT07668401: AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose WeightClinicalTrials.gov
09
NCT07400107: AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightClinicalTrials.gov
Audit and handoff

Keep the exact record attached.